2,271
Views
4
CrossRef citations to date
0
Altmetric
Clinical Study

Perceived barriers and attitudes toward arteriovenous fistula creation and use in hemodialysis patients in Palestine

, , &
Pages 343-349 | Received 28 Oct 2019, Accepted 12 Mar 2020, Published online: 25 Apr 2020

References

  • NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis. 2001;37(Suppl. 1):S137–S181.
  • Ethier JE, Lindsay RM, Barre PE, et al. Clinical practice guidelines for vascular access. Canadian Society of Nephrology. J Am SocNephrol. 1999;10(Suppl. 13):S297–S305.
  • NKF-KDOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48(Suppl. 1):S248–S272.
  • Tordoir J, Canaud B, Haage P, et al. European best practice guidelines (EBPG) on vascular access. Nephrol Dial Transplant. 2007;22(Suppl. 2):ii88–ii117.
  • Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am SocNephrol. 1996;7:523–535.
  • Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Dis. 2002;39(1):92–101.
  • Huber TS, Carter JW, Carter RL, et al. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg. 2003;38(5):1005–1011.
  • Pisoni RL, Young EW, Dykstra DM, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1):305–316.
  • Polkinghorne KR, Chin GK, MacGinley RJ, et al. KHA-CARI Guideline: vascular access – central venous catheters, arteriovenous fistulae and arteriovenous grafts. Nephrology (Carlton). 2013;18(11):701–705.
  • Navuluri R, Regalado S. The KDOQI 2006 vascular access update and fistula first program synopsis. Semin Intervent Radiol. 2009;26(02):122–124.
  • Kukita K, Ohira S, Amano I, et al. 2011 update Japanese society for dialysis therapy guidelines of vascular access construction and repair for chronic hemodialysis. Ther Apher Dial. 2015;19(1):1–39.
  • Dhingra RK, Young EW, Hulbert-Shearon TE, et al. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int. 2001;60(4):1443–1451.
  • Astor BC, Eustace JA, Powe NR, et al. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16(5):1449–1455.
  • Polkinghorne KR, McDonald SP, Atkins RC, et al. Vascular access and all-cause mortality: a propensity score analysis. J Am SocNephrol. 2004;15(2):477–486.
  • Banerjee T, Kim SJ, Astor B, et al. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014;64(6):954–961.
  • United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2017.
  • Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2(5):1043–1053.
  • Ministry of Health, Palestinian Health Information Center. Health Annual Report, Palestine 2015. 2016; [cited 2017 Feb 17]. Available from: http://site.moh.ps/Content/Books/NWNJXX7RJ92Bn4f5EGYiH43a2tjAAzKBnseGnEUCaqWqYZndsbCcPy_JQWguvkHTR4Xk4zUpdT45ooWxH11BhIbVAxwpGWy2wiwHdGcM5K7aZ.pdf
  • Ministry of Health, Palestinian Health Information Center. Health Annual Report, Palestine 2016. 2017; [cited 2018 Jan 20]. Available from: http://www.site.moh.ps/Content/Books/ZxRcynmiUofNqt66u4CrHRgmJR6Uv7z77srjjIEAho6xnz5V3rgLTu_RhO7xf2j2VusNiIvWkjwp84yXHLdGleB97gKrHHI5iZ9oPJ25owGEN.pdf
  • Lacson E, Jr.,Wang W, Hakim RM, et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis. 2009;53(1):79–90.
  • Ishani A, Collins AJ, Herzog CA, et al. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int. 2005;68(1):311–318.
  • Pisoni RL, Arrington CJ, Albert JM, et al. Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis. 2009;53(3):475–491.
  • Momeni A, Mardani S, Kabiri M, et al. Comparison of complications of arteriovenous fistula with permanent catheter in haemodialysis patients: a six-month follow-up. Adv Biomed Res. 2017;6(1):106.
  • Wasse H, Kutner N, Zhang R, et al. Association of initial hemodialysis vascular access with patient-reported health status and quality of life. Clin J Am Soc Nephrol. 2007;2(4):708–714.
  • Schon D, Blume SW, Niebauer K, et al. Increasing the use of arteriovenous fistula in hemodialysis: economic benefits and economic barriers. Clin J Am Soc Nephrol. 2007;2(2):268–276.
  • Foley RN, Chen SC, Collins AJ. Hemodialysis access at initiation in the United States, 2005 to 2007: still “catheter first.” Hemodial Int. 2009;13(4):533–542.
  • Anwar S, Atieh AO, Shamasneh A, et al. Predialysis nephrology care amongst Palestinian hemodialysis patients and its impact on initial vascular access type. Renal Failure. 2020;42(1):200–206.
  • Kim DH, Park JI, Lee JP, et al. The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients. Renal Failure. 2020;42(1):30–39.
  • Bay WH, Van Cleef S, Owens M. The hemodialysis access: preferences and concerns of patients, dialysis nurses and technicians, and physicians. Am J Nephrol. 1998;18(5):379–383.
  • Lopez-Vargas PA, Craig JC, Gallagher MP, et al. Barriers to timely arteriovenous fistula creation: a study of providers and patients. Am J Kidney Dis. 2011;57(6):873–882.
  • Greer RC, Ameling JM, Cavanaugh KL, et al. Specialist and primary care physicians’ views on barriers to adequate preparation of patients for renal replacement therapy: a qualitative study. BMC Nephrol. 2015;16(1):37.
  • Xi W, Harwood L, Diamant MJ, et al. Patient attitudes towards the arteriovenous fistula: a qualitative study on vascular access decision making. Nephrol Dial Transplant. 2011;26(10):3302–3308.
  • Morton RL, Tong A, Howard K, et al. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ. 2010;340:c112–c112.
  • Kosa SD, Bhola C, Lok CE. Hemodialysis patients’ satisfaction and perspectives on complications associated with vascular access related interventions: are we listening? J Vasc Access. 2016;17(4):313–319.
  • Murray MA, Thomas A, Wald R, et al. Are you SURE about your vascular access? Exploring factors influencing vascular access decisions with chronic hemodialysis patients and their nurses. Cannt J. 2016;26(2):21–28.
  • Cavanaugh KL, Wingard RL, Hakim RM, et al. Patient dialysis knowledge is associated with permanent arteriovenous access use in chronic hemodialysis. Clin J Am Soc Nephrol. 2009;4(5):950–956.
  • Vassalotti JA, Jennings WC ,Beathard GA, et al. Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial. 2012;25(3):303–310.
  • Smith GE, Gohil R, Chetter IC. Factors affecting the patency of arteriovenous fistula for dialysis access. J Vasc Surg. 2012;55(3):849–855.
  • Donca IZ, Wish JB. Systemic barriers to optimal hemodialysis access. SeminNephrol. 2012;32(6):519–529.